Anti-tumor drug, medicament, composition, and use thereof

US7674770B2 · kind B2 · utility

Assignee

• GENE SIGNAL INTERNATIONAL SA · CH

Inventors

• Sylvie Colin · Paris, FR
• Salman Al-Mahmood · Paris, FR

Key dates

• Filing date: Apr 11, 2007
• Grant date: Mar 9, 2010
• Expiry date: Jun 2, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K14/47
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

An active polypeptide comprising the amino acid sequence of SEQ ID NO: 3, or having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of SEQ ID NO: 3, or fragments thereof having at least 21 contiguous amino acids, or peptides having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of the fragments, provided that the polypeptide is not SEQ ID NO: 2. A method for inhibiting cancer and/or tumour growth comprising administering to a subject in need thereof an effective amount of the active polypeptide.